Ou, Horng-Yih
University College Dublin · University of Ulster
6 papers on CoChatORCID 0000-0002-3350-6548
Most cited papers
- Verified
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
Garvey, W. T., Frias, J. P., Jastreboff, A. M., le Roux, C. W., Sattar, N., Aizenberg, D., Mao, H., Zhang, S., Ahmad, N. N., Bunck, M. C., et al. (2023) · The Lancet
Pharmacology and Obesity TreatmentDiabetes Treatment and Management
Cited by 792
- Verified
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial.
Del Prato, S., Kahn, S. E., Pavo, I., Weerakkody, G. J., Yang, Z., Doupis, J., Aizenberg, D., Wynne, A. G., Riesmeyer, J. S., Heine, R. J., et al. (2021) · The Lancet
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 684
- Verified
A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes
Wu, H.-T., Ou, H.-Y., Hung, H.-C., Su, Y.-C., Lu, F.-H., Wu, J.-S., Yang, Y.-C., Wu, C.-L., & Chang, C.-J. (2016) · Diabetologia
Adipokines, Inflammation, and Metabolic DiseasesLiver Disease Diagnosis and Treatment
Cited by 96
- Verified
The role of hepassocin in the development of non-alcoholic fatty liver disease
Wu, H.-T., Lu, F.-H., Ou, H.-Y., Su, Y.-C., Hung, H.-C., Wu, J.-S., Yang, Y.-C., Wu, C.-L., & Chang, C.-J. (2013) · Journal of Hepatology
Liver Disease Diagnosis and TreatmentLiver physiology and pathology
Cited by 92
- Verified
Comparison of the Current Diagnostic Criterion of HbA1c with Fasting and 2-Hour Plasma Glucose Concentration
Karnchanasorn, R., Huang, J., Ou, H.-Y., Feng, W., Chuang, L.-M., Chiu, K. C., & Samoa, R. (2016) · Journal of Diabetes Research
Diabetes Management and ResearchDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 59
- Verified
Discovery of a role of the novel hepatokine, hepassocin, in obesity
Huang, R., Li, C., Du, Y., Cheng, K., Lin, C., Hu, C., Wu, J. S., Chang, C., Wu, H., & Ou, H. (2020) · BioFactors
Adipokines, Inflammation, and Metabolic DiseasesLiver Disease Diagnosis and Treatment
Cited by 24
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free